Aspect Partners’s Eli Lilly LLY Stock Holding History

Aspect Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Hold	101	–	–	0.05%	102
2026 Q1	$92.9K	Hold	101	–	–	0.04%	108
2025 Q4	$109K	Buy	101 +7	+7%	+$6.69K	0.05%	102
2025 Q3	$71.7K	Sell	94 -251	-73%	-$187K	0.03%	130
2025 Q2	$269K	Buy	345 +250	+263%	+$194K	0.13%	69
2025 Q1	$78.5K	Hold	95	–	–	0.04%	111
2024 Q4	$73.3K	Sell	95 -4	-4%	-$3.31K	0.04%	111
2024 Q3	$87.7K	Hold	99	–	–	0.05%	98
2024 Q2	$89.6K	Hold	99	–	–	0.05%	93
2024 Q1	$77K	Hold	99	–	–	0.06%	100
2023 Q4	$57.7K	Buy	+99	New	+$57.8K	0.04%	108

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aspect Partners's LLY Position: Q2 2026 in Review

Aspect Partners held its Eli Lilly (LLY) position steady in Q2 2026 at 101 shares worth $121K. The position accounts for 0.05% of the portfolio, ranked #102.

Aspect Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $269K in Q2 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Aspect Partners held 101 shares of Eli Lilly worth $121K as of Q2 2026.
Aspect Partners left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.05% of Aspect Partners's portfolio in Q2 2026, its #102 holding.
Aspect Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
Aspect Partners's Eli Lilly position peaked at $269K in Q2 2025.
1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.